Chemkart India Lists Flat on BSE SME, Gains Nearly 4% in Early Trade

Mumbai, 14 July 2025: Chemkart India Ltd, a Mumbai-based player in health and food ingredients, made a cautious yet promising debut on the BSE SME platform today. The stock opened at ₹250 per share, registering a marginal 0.8% gain over its issue price of ₹248. However, it gathered momentum in early trade, climbing as high as ₹259.70-marking a near 4% intraday rise.

As of 11:01 AM on 14 July 2025, Chemkart India Ltd. showed a positive price movement in early trading hours. The lowest price recorded during the session was ₹250.00. By 11:01 AM, the stock was trading at ₹259.00, up by ₹9.50 or 3.83% from the previous close. The total traded volume stood at 10,94,400 shares, indicating active investor participation. The bid and ask prices at that moment were ₹257.00 and ₹259.00, suggesting steady demand and positive market sentiment in the Trading sector.

Stock Opens Steady, Strengthens Through Early Trading Hours

Chemkart India began trading at ₹250.00 and gradually gained traction, reaching an intraday high of ₹259.70 by 10:10 AM IST. The stock remained above its issue price throughout the session. Key performance highlights include:

• Opening Price: ₹250.00
• Day’s High: ₹259.70
• Day’s Low: ₹250.00
• Previous Close (Issue Price): ₹248.00
• VWAP: ₹251.76
• Turnover: ₹23.71 crore
• Traded Quantity: 9.42 lakh shares
• Market Capitalisation (Full): ₹314.21 crore
• Free-Float Market Cap: ₹60.19 crore
• 52-Week Range: ₹250.00 – ₹259.70
• Price Band: ₹237.50 – ₹262.50

₹80 Crore IPO Sees Mixed Structure of Fresh Issue and OFS

Chemkart’s IPO was a blend of new equity and stake sale. The issue comprised:

• Fresh Issue: 26 lakh shares raising ₹64.48 crore
• Offer-for-Sale (OFS): 6.3 lakh shares raising ₹15.6 crore
• IPO Size: ₹80.08 crore
• Price Band: ₹236 – ₹248
• Lot Size: 600 shares
• Issue Period: 7-9 July 2025

The net proceeds from the fresh issue will be used to establish a new manufacturing facility through subsidiary Easy Raw Materials, repay outstanding debt, and support general corporate needs. The company will not receive any proceeds from the OFS component.

Company Focused on Expanding India’s Nutritional Supplement Landscape

Founded in 2020, Chemkart India Ltd operates in the rapidly growing health and wellness segment. It specialises in supplying and distributing food-grade ingredients across seven verticals:

• Amino Acids
• Health Supplements
• Herbal Extracts
• Nucleotides
• Proteins
• Sports Nutrition
• Vitamins

With rising demand for dietary and sports nutrition products in both domestic and global markets, the company aims to strengthen its supply chain, increase manufacturing capacities, and deepen its footprint in wellness-based FMCG sectors.

Early Gains Reflect Investor Optimism Amid Growing Sectoral Demand

Despite a modest start, Chemkart India’s ability to hold above its issue price and reach new highs suggests early investor confidence in its business model and growth outlook. Market participants are expected to watch closely for listing day volume trends and medium-term expansion milestones

Disclaimer:  At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations